However, there is no evidence to support a robust correlation between CD5 cells and NACT response in patients with breast cancer. CD5-positivity correlates with tumor responses in blood malignancies, but this association does not appear to be as strong regarding NACT for breast cancer. Here, CD5 is linked to breast carcinoma.